{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:53:49Z","timestamp":1776081229269,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.repc.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:24:29Z","timestamp":1773249869000},"page":"179-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seeing beneath the surface: Are current risk scores enough in hypertrophic cardiomyopathy?"],"prefix":"10.1016","volume":"45","author":[{"given":"Pedro","family":"Silva Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Aguiar Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2026.03.002_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.761860","article-title":"The impact of ischemia assessed by magnetic resonance on functional, arrhythmic, and imaging features of hypertrophic cardiomyopathy","volume":"8","author":"Aguiar Rosa","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.repc.2026.03.002_bib0060","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.3390\/ijms241914845","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: a perspective from fibroblasts","volume":"24","author":"Schlittler","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.repc.2026.03.002_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102789","article-title":"Ion channel impairment and myofilament Ca2+ sensitization: two parallel mechanisms underlying arrhythmogenesis in hypertrophic cardiomyopathy","volume":"10","author":"Santini","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.repc.2026.03.002_bib0070","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","article-title":"Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines","volume":"44","author":"Wang","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2026.03.002_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2025.04.030","article-title":"The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy","volume":"289","author":"Ravi","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2026.03.002_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","article-title":"Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis","volume":"17","author":"Kiaos","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2026.03.002_bib0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.03.002_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.repc.2025.12.007","article-title":"Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines \u2013 LGE remains tough to beat","volume":"45","author":"Amador","year":"2026","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2026.03.002_bib0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1148\/radiol.10090526","article-title":"Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging","volume":"258","author":"Harrigan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.repc.2026.03.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010489","article-title":"Late gadolinium enhancement-dispersion mapping: a new magnetic resonance imaging technique to assess prognosis in patients with hypertrophic cardiomyopathy and low-intermediate 5-year risk of sudden death","volume":"13","author":"Aquaro","year":"2020","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:00:14Z","timestamp":1776078014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255126000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0870255126000636"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2026.03.002","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seeing beneath the surface: Are current risk scores enough in hypertrophic cardiomyopathy?","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2025.12.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Portuguesa de Cardiologia.","name":"copyright","label":"Copyright"}]}}